These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17570105)

  • 1. Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols?
    Rook GA; Lowrie DB; Hernàndez-Pando R
    J Infect Dis; 2007 Jul; 196(2):191-8. PubMed ID: 17570105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?
    Rook GA; Hernández-Pando R; Zumla A
    J Infect Dis; 2009 Mar; 199(5):613-8. PubMed ID: 19199549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83.
    Yu DH; Hu XD; Cai H
    Gene Ther; 2008 May; 15(9):652-9. PubMed ID: 18288210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel prophylactic and therapeutic vaccine against tuberculosis.
    Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Inoue Y; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
    Vaccine; 2009 May; 27(25-26):3267-70. PubMed ID: 19200841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta regulates pathology but not tissue CD8+ T cell dysfunction during experimental Trypanosoma cruzi infection.
    Martin DL; Postan M; Lucas P; Gress R; Tarleton RL
    Eur J Immunol; 2007 Oct; 37(10):2764-71. PubMed ID: 17823982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
    Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P
    Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability.
    Ordway D; Higgins DM; Sanchez-Campillo J; Spencer JS; Henao-Tamayo M; Harton M; Orme IM; Gonzalez Juarrero M
    J Leukoc Biol; 2007 Nov; 82(5):1221-9. PubMed ID: 17699612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of anti-interleukin-4 antibody when administered in a murine model of tuberculosis infection.
    Roy E; Brennan J; Jolles S; Lowrie DB
    Tuberculosis (Edinb); 2008 May; 88(3):197-202. PubMed ID: 18096435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil.
    de Araújo-Filho JA; Vasconcelos AC; Martins de Sousa E; Kipnis A; Ribeiro E; Junqueira-Kipnis AP
    Tuberculosis (Edinb); 2008 Sep; 88(5):474-81. PubMed ID: 18676203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models.
    Kim S; Fridlender ZG; Dunn R; Kehry MR; Kapoor V; Blouin A; Kaiser LR; Albelda SM
    J Immunother; 2008 Jun; 31(5):446-57. PubMed ID: 18463540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.
    Maxeiner JH; Karwot R; Sauer K; Scholtes P; Boross I; Koslowski M; Türeci O; Wiewrodt R; Neurath MF; Lehr HA; Finotto S
    Cancer Res; 2009 Apr; 69(7):3069-76. PubMed ID: 19318584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy.
    Zárate-Bladés CR; Bonato VL; da Silveira EL; Oliveira e Paula M; Junta CM; Sandrin-Garcia P; Fachin AL; Mello SS; Cardoso RS; Galetti FC; Coelho-Castelo AA; Ramos SG; Donadi EA; Sakamoto-Hojo ET; Passos GA; Silva CL
    J Gene Med; 2009 Jan; 11(1):66-78. PubMed ID: 19035575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
    Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
    Rolle CE; Carrio R; Malek TR
    Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cytotoxicity of CD8+ T cells in multi-drug-resistant tuberculosis. A preliminary report.
    Sada-Ovalle I; Torre-Bouscoulet L; Valdez-Vázquez R; Lascurain R
    Respirology; 2009 May; 14(4):574-8. PubMed ID: 19192219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.
    Cao DY; Yang JY; Yue SQ; Tao KS; Song ZS; Wang DS; Yang YL; Dou KF
    Cell Immunol; 2009; 259(1):13-20. PubMed ID: 19545862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis: vaccines in the pipeline.
    Ly LH; McMurray DN
    Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.